JP2006514107A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514107A5 JP2006514107A5 JP2005502630A JP2005502630A JP2006514107A5 JP 2006514107 A5 JP2006514107 A5 JP 2006514107A5 JP 2005502630 A JP2005502630 A JP 2005502630A JP 2005502630 A JP2005502630 A JP 2005502630A JP 2006514107 A5 JP2006514107 A5 JP 2006514107A5
- Authority
- JP
- Japan
- Prior art keywords
- boc
- added
- diethyl ether
- reaction mixture
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- -1 N-Boc-piperidin-4-yl Chemical group 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- DARTVAOOTJKHQW-UHFFFAOYSA-N tert-butyl 4-[(4-methylphenyl)sulfonyloxymethyl]piperidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1CCN(C(=O)OC(C)(C)C)CC1 DARTVAOOTJKHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203821A SE0203821D0 (sv) | 2002-12-20 | 2002-12-20 | Chemical Compounds |
| SE0300499A SE0300499D0 (sv) | 2003-02-24 | 2003-02-24 | Chemical compounds |
| SE0301425A SE0301425D0 (sv) | 2003-05-15 | 2003-05-15 | Chemical compounds |
| PCT/SE2003/002008 WO2004056773A1 (en) | 2002-12-20 | 2003-12-18 | Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514107A JP2006514107A (ja) | 2006-04-27 |
| JP2006514107A5 true JP2006514107A5 (https=) | 2007-02-01 |
Family
ID=32685861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005502630A Pending JP2006514107A (ja) | 2002-12-20 | 2003-12-18 | ケモカイン受容体ｃｃｒ５のモジュレーターとしての新規なピペリジン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20060189650A1 (https=) |
| EP (1) | EP1572650A1 (https=) |
| JP (1) | JP2006514107A (https=) |
| KR (1) | KR20050084424A (https=) |
| AR (1) | AR042628A1 (https=) |
| AU (1) | AU2003288856B2 (https=) |
| BR (1) | BR0317459A (https=) |
| CA (1) | CA2508624A1 (https=) |
| CL (1) | CL2003002678A1 (https=) |
| CO (1) | CO5570665A2 (https=) |
| IS (1) | IS7942A (https=) |
| MX (1) | MXPA05006381A (https=) |
| NZ (1) | NZ540780A (https=) |
| PL (1) | PL377768A1 (https=) |
| TW (1) | TW200505856A (https=) |
| UY (1) | UY28139A1 (https=) |
| WO (1) | WO2004056773A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103818D0 (sv) | 2001-11-15 | 2001-11-15 | Astrazeneca Ab | Chemical compounds |
| SE0301369D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
| SE0302090D0 (sv) * | 2003-07-16 | 2003-07-16 | Astrazeneca Ab | Chemical compounds |
| ATE361911T1 (de) * | 2003-07-31 | 2007-06-15 | Astrazeneca Ab | Piperidinderivate als ccr5-rezeptormodulatoren |
| TW200610761A (en) * | 2004-04-23 | 2006-04-01 | Astrazeneca Ab | Chemical compounds |
| RU2006146608A (ru) | 2004-06-09 | 2008-07-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | ОКТАГИДРОПИРРОЛО[3,4-с]-ПРОИЗВОДНЫЕ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ АГЕНТОВ |
| SE0401656D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | Chemical compounds |
| SE0401657D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | Chemical compounds |
| US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
| WO2007045573A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
| CA2658984C (en) | 2006-08-16 | 2014-12-02 | Joshua Kennedy-Smith | Non-nucleoside reverse transcriptase inhibitors |
| CA2664364A1 (en) * | 2006-09-28 | 2008-04-03 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors |
| CN101553483B (zh) | 2006-12-13 | 2013-04-17 | 弗·哈夫曼-拉罗切有限公司 | 作为非核苷逆转录酶抑制剂的2-(哌啶-4-基)-4-苯氧基-或苯基氨基-嘧啶衍生物 |
| SG181900A1 (en) | 2009-12-23 | 2012-08-30 | Ironwood Pharmaceuticals Inc | Crth2 modulators |
| US20130216552A1 (en) | 2010-07-12 | 2013-08-22 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| WO2012009134A1 (en) | 2010-07-12 | 2012-01-19 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| WO2018068296A1 (en) | 2016-10-14 | 2018-04-19 | Merck Sharp & Dohme Corp. | PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
| CN113444065A (zh) * | 2021-06-29 | 2021-09-28 | 浙江得乐康食品股份有限公司 | 一种莽草酸磺化物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9100513A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| EP1013276A1 (en) * | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalkanes as CCR5 modulators |
| AU5600100A (en) * | 1999-06-11 | 2001-01-02 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
| GB0011838D0 (en) * | 2000-05-17 | 2000-07-05 | Astrazeneca Ab | Chemical compounds |
| GB0013060D0 (en) * | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
| GB0108046D0 (en) * | 2001-03-30 | 2001-05-23 | Astrazeneca Ab | Chemical compounds |
| WO2003062224A1 (en) * | 2002-01-17 | 2003-07-31 | Eli Lilly And Company | Aza-cyclic compounds as modulators of acetylcholine receptors |
-
2003
- 2003-12-17 AR ARP030104682A patent/AR042628A1/es not_active Application Discontinuation
- 2003-12-18 KR KR1020057011450A patent/KR20050084424A/ko not_active Withdrawn
- 2003-12-18 EP EP03781235A patent/EP1572650A1/en not_active Withdrawn
- 2003-12-18 CL CL200302678A patent/CL2003002678A1/es unknown
- 2003-12-18 US US10/539,859 patent/US20060189650A1/en not_active Abandoned
- 2003-12-18 WO PCT/SE2003/002008 patent/WO2004056773A1/en not_active Ceased
- 2003-12-18 MX MXPA05006381A patent/MXPA05006381A/es active IP Right Grant
- 2003-12-18 PL PL377768A patent/PL377768A1/pl not_active Application Discontinuation
- 2003-12-18 JP JP2005502630A patent/JP2006514107A/ja active Pending
- 2003-12-18 CA CA002508624A patent/CA2508624A1/en not_active Abandoned
- 2003-12-18 NZ NZ540780A patent/NZ540780A/en unknown
- 2003-12-18 AU AU2003288856A patent/AU2003288856B2/en not_active Ceased
- 2003-12-18 BR BR0317459-0A patent/BR0317459A/pt not_active IP Right Cessation
- 2003-12-19 TW TW092136170A patent/TW200505856A/zh unknown
- 2003-12-19 UY UY28139A patent/UY28139A1/es unknown
-
2005
- 2005-06-13 CO CO05057099A patent/CO5570665A2/es not_active Application Discontinuation
- 2005-07-18 IS IS7942A patent/IS7942A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514107A5 (https=) | ||
| JP2004527511A5 (https=) | ||
| JP2018502909A5 (https=) | ||
| JP2022031717A5 (https=) | ||
| CN100355732C (zh) | 2－氯－5－氟－烟酸酯及酸的制备方法 | |
| JP2004182741A5 (https=) | ||
| JP2005514381A5 (https=) | ||
| JP2013056912A (ja) | ２−置換−５−（１−アルキルチオ）アルキルピリミジンの製造方法 | |
| CN110337434B (zh) | 制备2-氰基咪唑化合物的方法 | |
| CN103787855B (zh) | 不对称催化合成(s)-芳姜黄酮的新方法 | |
| CN104136409B (zh) | 用于制备取代的苯丙酮的方法 | |
| CN105189467B (zh) | 制备哒嗪酮化合物的方法 | |
| JPH10512874A (ja) | ２−（置換ベンゾイル）−１，３−シクロヘキサンジオン類の製造方法 | |
| CN110229136A (zh) | 一种派洛宁类硫酮的合成方法 | |
| CN111454315B (zh) | 一种雄甾-16-烯-3β-醇的合成方法 | |
| JP2007502844A5 (https=) | ||
| CN116082181A (zh) | 一种制备3-氨基-5-乙氧基-苯甲酸的方法 | |
| CN104672168B (zh) | 一种2‑甲基‑4‑三氟甲基噻唑‑5‑甲酸的制备方法 | |
| JP5470065B2 (ja) | （ｅ）−２−ヘキセニル＝（ｅ）−２−ヘキセノアートの製造方法 | |
| CN103724248B (zh) | 维格列汀工艺杂质的制备方法 | |
| JP2008533169A5 (https=) | ||
| CN108264492B (zh) | 一种氧二氮杂环化合物的制备工艺及应用 | |
| Masuda et al. | New simple syntheses of (E)-1-azido-(or thiocyanato)-alk-1-enes from alk-1-ynes by hydroboration | |
| JP4538993B2 (ja) | β−ケトニトリル誘導体の製法 | |
| JP2006516125A5 (https=) |